Literature DB >> 26361998

Infectious disease surveillance in China.

Bing-Ke Bai1, Zhe Xu2, Hong-Hui Shen3.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26361998      PMCID: PMC7127739          DOI: 10.1016/j.jinf.2015.08.010

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
To the Editors: In this journal, Freeman and colleagues described their evaluation of a national microbiological surveillance system for automated outbreak detection in England. The Chinese government had also established a similar surveillance system after the outbreak of severe acute respiratory syndrome in 2003. That system is comprised of a web-based disease reporting system and the National Infectious Diseases Monitoring Information System Database. These resources have helped to strengthen the Chinese infectious disease prevention and control strategies. For example, the outbreaks of H1N1 influenza in 2013 and H7N9 influenza in 2009 were swiftly detected and effectively controlled. Moreover, the outbreak of imported wild-type poliovirus in 2011 was quickly detected by this system, and the vulnerable population was vaccinated, which led to the successful termination of the outbreak within 1.5 months after laboratory confirmation of the index case. In addition to China's population-based vaccination programs, the national microbiological surveillance system has substantially contributed to the control of infectious diseases in China during the last 11 years (Fig. 1 ). According to Chinese governmental reports, severe acute respiratory syndrome was eradicated in 2004, and during the last 3 years there have only been four cases of plague and no cases of diphtheria or filariasis. Since 2004, >50% decreases have been reported in the number of cases of anthrax, cholera, leptospirosis, epidemic cerebrospinal meningitis, neonatal tetanus, typhus fever, epidemic hemorrhagic fever, typhoid and paratyphoid fever, un-typed viral hepatitis, hepatitis A, gonorrhea, and bacterial and amebic dysentery. Furthermore, although the number of reported cases of kala-azar, rabies, epidemic encephalitis B, malaria, and rubella had initially risen from 2004 to 2007–2010, a subsequent downward trend in recent years has resulted in a lower number of cases in 2014 (vs. 2004). Similarly, although the number of reported mumps cases had increased from 2004 to 2012, a 60.9% decrease from 2012 to 2014 resulted in a lower number of cases in 2014 (vs. 2004). Although the numbers of reported hepatitis B and leprosy cases in 2014 were higher than those in 2004, the 2014 numbers were lower than those in the peak years of 2009 and 2012, respectively. Finally, the number of pulmonary tuberculosis cases has decreased slowly during the past decade, from 1,259,308 in 2005 to 889,381 cases in 2014.
Figure 1

The number of reported infectious disease cases in China from 2004 to 2014. A) Leprosy, kala-azar, anthrax, cholera, leptospirosis, and epidemic cerebrospinal meningitis. B) Neonatal tetanus, rabies, echinococcosis, typhus fever, pertussis, and schistosomiasis. C) Epidemic encephalitis B, epidemic hemorrhagic fever, hepatitis E, AIDS, dengue fever, and typhoid and paratyphoid fever. D) Brucellosis, malaria, scarlet fever, un-typed viral hepatitis, hepatitis A, and acute hemorrhagic conjunctivitis. E) Rubella, hepatitis C, gonorrhea, measles, influenza, and syphilis. F) Mumps, bacterial and amebic dysentery, other infectious diarrhea, hepatitis B, pulmonary tuberculosis, and hand-foot-and-mouth disease. Un-typed viral hepatitis: all viral hepatitis cases except cases of hepatitis A, B, C and E. Other infectious diarrhea: all cases of infectious diarrhea that were not listed above.

The number of reported infectious disease cases in China from 2004 to 2014. A) Leprosy, kala-azar, anthrax, cholera, leptospirosis, and epidemic cerebrospinal meningitis. B) Neonatal tetanus, rabies, echinococcosis, typhus fever, pertussis, and schistosomiasis. C) Epidemic encephalitis B, epidemic hemorrhagic fever, hepatitis E, AIDS, dengue fever, and typhoid and paratyphoid fever. D) Brucellosis, malaria, scarlet fever, un-typed viral hepatitis, hepatitis A, and acute hemorrhagic conjunctivitis. E) Rubella, hepatitis C, gonorrhea, measles, influenza, and syphilis. F) Mumps, bacterial and amebic dysentery, other infectious diarrhea, hepatitis B, pulmonary tuberculosis, and hand-foot-and-mouth disease. Un-typed viral hepatitis: all viral hepatitis cases except cases of hepatitis A, B, C and E. Other infectious diarrhea: all cases of infectious diarrhea that were not listed above. The reported number of other infectious diseases has increased in 2014 in China, compared to that previously observed (Fig. 1). This is believed to be attributable to microbes being able to spread more easily now than before owing to a dirty environment, changed climate, and population migration. The national microbiological surveillance system has been able to effectively and promptly detect this change in status. Although China had effectively reduced the number of pertussis cases between 2004 and 2009, the number of cases was significantly higher in 2014. Although fewer measles cases were reported in 2014 (vs. 2004), the 2014 incidence was 8.5-fold higher than the incidence in 2012. The number of reported hepatitis E cases has also increased by >60% since 2004. Similarly, the numbers of reported acute hemorrhagic conjunctivitis and influenza cases were 3.1-fold and 2.6-fold higher in 2014, respectively, compared to the numbers in 2004 (excluding the outbreaks in 2010 and 2009, respectively). Furthermore, the numbers of reported syphilis, brucellosis, scarlet fever, schistosomiasis, echinococcosis, and hepatitis C cases have exhibited fluctuating or sharply increasing trends from 2004 to 2014, with approximately 3–6-fold more cases reported in 2014 (vs. 2004). Moreover, the number of reported hand-foot-and-mouth disease cases has increased by >30-fold, from 83,344 cases in 2007 to 2,778,861 cases in 2014. A recent increase in dengue fever cases has also emerged over the last 2 years, with a 180-fold increase between 2004 and 2014. Surprisingly, a large year-over-year increase in the number of AIDS cases was reported, from 3054 in 2004 to 45,145 in 2014. In conclusion, both China and England have effectively implemented national microbiological surveillance systems. Adoption of similar systems by other countries, especially Africa countries, may enable public health authorities to quickly collect information and make effective decisions to combat potential and ongoing outbreaks.

Conflict of interest

None declared.
  3 in total

1.  China boosts pandemic surveillance.

Authors:  Jane Qiu
Journal:  Nature       Date:  2009-08-27       Impact factor: 49.962

2.  Identification and control of a poliomyelitis outbreak in Xinjiang, China.

Authors:  Hui-Ming Luo; Yong Zhang; Xin-Qi Wang; Wen-Zhou Yu; Ning Wen; Dong-Mei Yan; Hua-Qing Wang; Fuerhati Wushouer; Hai-Bo Wang; Ai-Qiang Xu; Jing-Shan Zheng; De-Xin Li; Hui Cui; Jian-Ping Wang; Shuang-Li Zhu; Zi-Jian Feng; Fu-Qiang Cui; Jing Ning; Li-Xin Hao; Chun-Xiang Fan; Gui-Jun Ning; Hong-Jie Yu; Shi-Wen Wang; Da-Wei Liu; Dong-Yan Wang; Jian-Ping Fu; Ai-li Gou; Guo-Min Zhang; Guo-Hong Huang; Yuan-Sheng Chen; Sha-Sha Mi; Yan-Min Liu; Da-Peng Yin; Hui Zhu; Xin-Chun Fan; Xin-Lan Li; Yi-Xin Ji; Ke-Li Li; Hai-Shu Tang; Wen-Bo Xu; Yu Wang; Wei-Zhong Yang
Journal:  N Engl J Med       Date:  2013-11-21       Impact factor: 91.245

3.  Evaluation of a national microbiological surveillance system to inform automated outbreak detection.

Authors:  R Freeman; A Charlett; S Hopkins; A M O'Connell; N Andrews; J Freed; A Holmes; M Catchpole
Journal:  J Infect       Date:  2013-07-20       Impact factor: 6.072

  3 in total
  1 in total

1.  A retrospective analysis of malaria epidemiological characteristics in Yingjiang County on the China-Myanmar border.

Authors:  Fang Huang; Shi-Gang Li; Peng Tian; Xiang-Rui Guo; Zhi-Gui Xia; Shui-Sen Zhou; Hong-Ning Zhou; Xiao-Nong Zhou
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.